|

Trifluridine and Tipiracil Hydrochloride Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Also known as: 733030-01-8, Lonsurf, TAS 102, TAS 102,, TAS-102 +5 more

Pipeline

Phase 1: 1

Top Sponsors

  • Roswell Park Cancer Institute1

Indications

  • Stage IIIC Colorectal Cancer AJCC v81
  • Stage IIIB Colorectal Cancer AJCC v81
  • Stage IIIA Colorectal Cancer AJCC v81
  • Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v81
  • Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v81

Buffalo, New York1 trial

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Roswell Park Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.